Evidence map›Paper›PMID 36862407›Full record

ArticleJAMA network open2023

Estimated Burden of Stroke in China in 2020.

Wen-Jun Tu, Zhenping Zhao, Peng Yin, Lei Cao, Jingsheng Zeng, Huisheng Chen, Dongsheng Fan, Qi Fang, Pei Gao, Yuxiang Gu and 35 more

3 registry-linked trialsAbstract read
In one paragraph

Article in JAMA network open, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 406 papers, 13 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
406citing papers in PubMed, 13 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06817512 naactive not recruitingnot on this mapstarted 2025, after this paper: background citation

Health Effects of Vitamin K2 Supplementation on Skeletal Muscle and Neurological Function After Ischemic Stroke

TypeinterventionalSponsorHarbin Medical UniversityRan2025 to 2028Enrolled190ConditionsIschemic StrokeArmsVitamin K2, Placebo
NCT06853535 phase3recruitingnot on this mapstarted 2025, after this paper: background citation

Precision Antiplatelet Therapy Guided by Platelet Aggregation Function in Patients With Acute Ischemic STROKE

TypeinterventionalSponsorSichuan Provincial People's HospitalRan2025 to 2027Enrolled5,138ConditionsAcute Ischemic Stroke, Clopidogrel ResistanceArmsThe ticagrelor, The Clopidogrel
NCT07644234 phase4not yet recruitingnot on this mapstarted 2026, after this paper: background citation

Platelet Aggregation Function-Guided De-Escalation Antiplatelet Therapy in Patients With Acute Ischemic Stroke

TypeinterventionalSponsorSichuan Provincial People's HospitalRan2026 to 2029Enrolled3,836ConditionsIschemic Stroke, Transient Ischemic AttackArmsClopidogrel, Aspirin
3 · Its place in the literature

Who cites it

406 citing papers in PubMed, 13 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Clinical characteristics and outcomes of ischemic stroke despite appropriate oral anticoagulation for atrial fibrillation: A systematic review and meta-analysis of real-world studies.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025
    Pooled it
  7. Pooled it
  8. Effectiveness of intermittent theta burst stimulation (iTBS) on Post-Stroke motor dysfunction: A Meta-Analysis of randomized controlled trials.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025
    Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Pooled it
  13. Pooled it
  14. Trial
  15. Trial
  16. Trial
  17. Article
  18. Article
  19. Article
  20. [Personalized lower-limb gait assessment method based on musculoskeletal modeling and machine learning].Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi · 2026
    Article

346 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

45 authors.

Wen-Jun TuThe General Office of Stroke Prevention Project Committee, National Health Commission of the People's Republic of China, Beijing, China.
Zhenping ZhaoNational Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Peng YinNational Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Lei CaoThe General Office of Stroke Prevention Project Committee, National Health Commission of the People's Republic of China, Beijing, China.
Jingsheng ZengDepartment of Neurology, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Huisheng ChenDepartment of Neurology, The General Hospital of Northern Theater Command of the Chinese People's Liberation Army, Shenyang, China.
Dongsheng FanDepartment of Neurology, Peking University Third Hospital, Beijing, China.
Qi FangDepartment of Neurology, the First Affiliated Hospital of Soochow University, Suzhou, China.
Pei GaoPeking University School of Public Health, Beijing, China.
Yuxiang GuDepartment of Neurosurgery, Huashan Hospital Fudan University, Shanghai, China.
Guojun TanDepartment of Neurology, the Second Hospital of Hebei Medical University, Shijiazhuang, China.
Jianfeng HanDepartment of Neurology, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Li HeDepartment of Neurology, West China Hospital of Sichuan University, Chengdu, China.
Bo HuDepartment of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Yang HuaDepartment of Ultrasound Vascular, Xuanwu Hospital Capital Medical University, Beijing, China.
Dezhi KangDepartment of Neurosurgery, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China.
Hongyan LiDepartment of Neurology, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, China.
Jianmin LiuDepartment of Neurosurgery, Shanghai Changhai Hospital, Shanghai, China.
Yuanli LiuSchool of Health and Health Management Policy, Peking Union Medical College, Beijing, China.
Min LouDepartment of Neurology, the Second Affiliated Hospital of Zhejiang University, Hangzhou, China.
Benyan LuoDepartment of Neurology, the First Affiliated Hospital of Zhejiang University, Hangzhou, China.
Suyue PanDepartment of Neurology, Nanfang Hospital of Southern Medical University, Guangzhou, China.
Bin PengDepartment of Neurology, Peking Union Medical College Hospital, Beijing, China.
Lijie RenDepartment of Neurology, Shenzhen Second Hospital, Shenzhen, China.
Lihua WangDepartment of Neurology, the Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Jian WuDepartment of Neurology, Beijing Tsinghua Changgung Memoria Hospital, Beijing, China.
Yuming XuDepartment of Neurology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Yun XuDepartment of Neurology, Drum Tower Hospital Affiliated to Nanjing University School of Medicine, China.
Yi YangDepartment of Neurology, the First Bethune Hospital of Jilin University, Changchun, China.
Meng ZhangDepartment of Neurology, Daping Hospital, Army Medical University, Chongqing, China.
Shu ZhangDepartment of Cardiology, Fuwai Hospital, Chinese Academy of Medical Sciences, Beijing, China.
Liangfu ZhuDepartment of Cerebrovascular Disease, Henan Provincial People's Hospital, Zhengzhou, China.
Yicheng ZhuDepartment of Neurology, Peking Union Medical College Hospital, Beijing, China.
Zixiao LiDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Lan ChuDepartment of Neurology, the Affiliated Hospital of Guizhou Medical University, Guiyang, China.
Xiuli AnDepartment of Neurology, Harbin Second Hospital, Harbin, China.
Lingxiao WangThe General Office of Stroke Prevention Project Committee, National Health Commission of the People's Republic of China, Beijing, China.
Meng YinThe General Office of Stroke Prevention Project Committee, National Health Commission of the People's Republic of China, Beijing, China.
Mei LiChronic Noncommunicable Disease Prevention and Control Institute, Hebei Provincial Center for Disease Control and Prevention, Shijiazhuang, China.
Li YinDepartment of Chronic Disease, Hunan Provincial Center for Disease Control and Prevention, Changsha, China.
Wei YanChronic Noncommunicable Disease Prevention and Control Institute, Jiangxi Provincial Center for Disease Control and Prevention, Nanchang, China.
Chuan LiChronic Noncommunicable Disease Prevention and Control Institute, Guangdong Provincial Center for Disease Control and Prevention, Guangzhou, China.
Junli TangChronic Noncommunicable Disease Prevention and Control Institute, Shandong Provincial Center for Disease Control and Prevention, Jinan, China.
Maigeng ZhouNational Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Longde WangThe General Office of Stroke Prevention Project Committee, National Health Commission of the People's Republic of China, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Importance: Stroke is the leading cause of death in China. However, recent data about the up-to-date stroke burden in China are limited. Objective: To investigate the urban-rural disparity of stroke burden in the Chinese adult population, including prevalence, incidence, and mortality rate, and disparities between urban and rural populations. Design, Setting, and Participants: This cross-sectional study was based on a nationally representative survey that included 676 394 participants aged 40 years and older. It was conducted from July 2020 to December 2020 in 31 provinces in mainland China. Main Outcomes and Measures: Primary outcome was self-reported stroke verified by trained neurologists during a face-to-face interviews using a standardized protocol. Stroke incidence were assessed by defining first-ever strokes that occurred during 1 year preceding the survey. Strokes causing death that occurred during the 1 year preceding the survey were considered as death cases. Results: The study included 676 394 Chinese adults (395 122 [58.4%] females; mean [SD] age, 59.7 [11.0] years). In 2020, the weighted prevalence, incidence, and mortality rates of stroke in China were 2.6% (95% CI, 2.6%-2.6%), 505.2 (95% CI, 488.5-522.0) per 100 000 person-years, and 343.4 (95% CI, 329.6-357.2) per 100 000 person-years, respectively. It was estimated that among the Chinese population aged 40 years and older in 2020, there were 3.4 (95% CI, 3.3-3.6) million incident cases of stroke, 17.8 (95% CI, 17.5-18.0) million prevalent cases of stroke, and 2.3 (95% CI, 2.2-2.4) million deaths from stroke. Ischemic stroke constituted 15.5 (95% CI, 15.2-15.6) million (86.8%) of all incident strokes in 2020, while intracerebral hemorrhage constituted 2.1 (95% CI, 2.1-2.1) million (11.9%) and subarachnoid hemorrhage constituted 0.2 (95% CI, 0.2-0.2) million (1.3%). The prevalence of stroke was higher in urban than in rural areas (2.7% [95% CI, 2.6%-2.7%] vs 2.5% [95% CI, 2.5%-2.6%]; P = .02), but the incidence rate (485.5 [95% CI, 462.8-508.3] vs 520.8 [95% CI, 496.3-545.2] per 100 000 person-years; P < .001) and mortality rate (309.9 [95% CI, 291.7-328.1] vs 369.7 [95% CI, 349.1-390.3] per 100 000 person-years; P < .001) were lower in urban areas than in rural areas. In 2020, the leading risk factor for stroke was hypertension (OR, 3.20 [95% CI, 3.09-3.32]). Conclusions and Relevance: In a large, nationally representative sample of adults aged 40 years or older, the estimated prevalence, incidence, and mortality rate of stroke in China in 2020 were 2.6%, 505.2 per 100 000 person-years, and 343.4 per 100 000 person-years, respectively, indicating the need for an improved stroke prevention strategy in the general Chinese population.

Indexed as

Ischemic StrokeStrokeAdultCerebral HemorrhageChinaCross-Sectional StudiesFemaleHumansMaleMiddle Aged

Identifiers

PMID36862407
PMCPMC9982699

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.